Bodo B. Beck

ORCID: 0000-0003-0495-7670
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Kidney Stones and Urolithiasis Treatments
  • Biomedical Research and Pathophysiology
  • Porphyrin Metabolism and Disorders
  • Renal Diseases and Glomerulopathies
  • Pediatric Urology and Nephrology Studies
  • Renal and related cancers
  • Genetic and Kidney Cyst Diseases
  • Ion Transport and Channel Regulation
  • Complement system in diseases
  • Metabolism and Genetic Disorders
  • Chronic Kidney Disease and Diabetes
  • Parathyroid Disorders and Treatments
  • Magnesium in Health and Disease
  • Hemoglobinopathies and Related Disorders
  • Pancreatic function and diabetes
  • Neonatal Health and Biochemistry
  • Pregnancy and preeclampsia studies
  • Glycosylation and Glycoproteins Research
  • Urological Disorders and Treatments
  • Renal Transplantation Outcomes and Treatments
  • Renal function and acid-base balance
  • Biochemical and Molecular Research
  • Therapeutic Uses of Natural Elements
  • Galectins and Cancer Biology
  • Genetic Syndromes and Imprinting

University of Cologne
2016-2025

University Hospital Cologne
2016-2025

Klinik und Poliklinik für Psychosomatik und Psychotherapie
2018-2024

University of South Alabama
2024

Centrum für Integrierte Onkologie
2010-2022

RELX Group (United States)
2018

Institute of Human Genetics
2016

University of Bonn
2013

Pediatric Nephrology of Alabama
2009

Boston Children's Hospital
2003-2009

Nephrotic syndrome (NS) is divided into steroid-sensitive (SSNS) and -resistant (SRNS) variants. SRNS causes end-stage kidney disease, which cannot be cured. While the disease mechanisms of NS are not well understood, genetic mapping studies suggest a multitude unknown single-gene causes. We combined homozygosity with whole-exome resequencing identified an ARHGDIA mutation that SRNS. demonstrated in complex RHO GTPases prominently expressed podocytes rat glomeruli. mutations (R120X G173V)...

10.1172/jci69134 article EN Journal of Clinical Investigation 2013-07-07

Bone densitometric data often are difficult to interpret in children and adolescents because of large inter- intraindividual variations bone size. Here, we propose a functional approach densitometry that addresses two questions: Is strength normally adapted the largest physiological loads, is, muscle force? force adequate for body size? To implement this approach, forearm cross-sectional area (CSA) mineral content (BMC) radial diaphysis were measured 349 healthy subjects from 6 19 years age...

10.1359/jbmr.2002.17.6.1095 article EN Journal of Bone and Mineral Research 2002-06-01

10.1038/ki.2011.336 article EN publisher-specific-oa Kidney International 2011-09-28

Primary hyperoxaluria type I (PH I) is caused by deficiency of the liver-specific enzyme alanine-glyoxylate:aminotransferase (AGT). Many mutations are known to perturb AGT protein folding. Vitamin B6 (B6) only specific drug available for treatment. Although has been used >40 years, controlled data on efficacy lacking. Therefore, this study investigated absolute and relative change urinary oxalate (Uox) excretion under increasing dosages B6, first prospective trial do so.B6 response was...

10.2215/cjn.06820613 article EN Clinical Journal of the American Society of Nephrology 2014-01-03

Treatment of congenital nephrotic syndrome (CNS) and steroid-resistant (SRNS) is demanding, renal prognosis poor. Numerous causative gene mutations have been identified in SRNS that affect the podocyte. In era high-throughput sequencing techniques, patients with nongenetic frequently escape scientific interest. We here present long-term data German CNS/SRNS Follow-Up Study, focusing on response to cyclosporin A (CsA) versus genetic disease.Cross-sectional longitudinal clinical were collected...

10.2215/cjn.07370715 article EN Clinical Journal of the American Society of Nephrology 2015-12-15

Primary hyperoxaluria type 2 is a rare inherited disorder of glyoxylate metabolism causing nephrocalcinosis, renal stone formation and ultimately kidney failure. Previously, primary was considered to have more favorable prognosis than 1, but earlier reports are limited by low patient numbers short follow up periods. Here we report on the clinical, genetic, biochemical findings from largest cohort patients with 2, obtained retrospective record review genetically confirmed cases in OxalEurope...

10.1016/j.kint.2019.08.018 article EN cc-by-nc-nd Kidney International 2019-09-03
Kathrin Burgmaier Leonie Violetta Brinker Florian Erger Bodo B. Beck Marcus R. Benz and 95 more Carsten Bergmann Olivia Boyer Laure Collard Claudia Dafinger Marc Fila Claudia Kowalewska Bärbel Lange-Sperandio Laura Massella Antonio Mastrangelo Djalila Mekahli Monika Miklaszewska Nadina Ortiz-Bruechle Ludwig Patzer Larisa Prikhodina Bruno Ranchin Nadejda Ranguelov Raphael Schild Tomáš Seeman Lale Sever Przemysław Sikora Maria Szczepańska Ana Teixeira Julia Thumfart Barbara Uetz Lutz T. Weber Elke Wühl Klaus Zerres Jörg Dötsch Franz Schaefer Max C. Liebau Loai Eid Klaus Arbeiter Nathalie Godefroid Jacques Lombet Aurélie De Mul Markus Feldkoetter Jakub Zieg Franziska Grundmann Matthias Galiano Bjoern Buchholz Anja Buescher Karsten Häffner Oliver Groß Ludwig Patzer Jun Oh Dieter Haffner Wanja M. Bernhardt Susanne Schaefer Simone Wygoda Jan Halbritter Ute Derichs Günter Klaus Felix Lechner Sabine Ponsel Jens König Hagen Staude Donald Wurm Martin Bald Michaela Geßner Neveen A. Soliman Gema Ariceta Juan David González-Rodríguez Francisco de la Cerda Ojeda Jérôme Harambat Denis Morin Claire Dossier Guillaume Dorval Rukshana Shroff Stella Stabouli Nakysa Hooman Francesca Mencarelli William Morello Germana Longo Francesco Emma Augustina Jankauskienė Katarzyna Taranta‐Janusz Ilona Zagożdżon Katarzyna Zachwieja Małgorzata Stańczyk Beata Bieniaś Mieczysław Litwin Aurelia Morawiec‐Knysak Alberto Caldas Afonso Oliver Dunand Andreea Liana Răchişan Gordana Miloševski‐Lomić Svetlana Papizh Rina Rus Houweyda Jilani Bahriye Atmış Ali Düzova Alper Soylu Cengiz Candan Salim Çalışkan Alev Yılmaz

10.1016/j.kint.2021.04.019 article EN Kidney International 2021-04-30

Abstract Cell-free DNA (cfDNA) analysis has become essential in cancer diagnostics and prenatal testing. We present cfNOMe , a two-in-one method of measuring cfDNA cytosine methylation nucleosome occupancy single assay using non-disruptive enzymatic conversion custom bioinformatic pipeline. show that better preserves fragmentation information than does bisulfite conversion. Whereas previously separate experiments were required to study either epigenetic marking, delivers reliable results for...

10.1186/s13073-020-00750-5 article EN cc-by Genome Medicine 2020-06-24

Over the last decade, advances in genetic techniques have resulted identification of rare hereditary disorders renal magnesium and salt handling. Nevertheless, approximately 20% all patients with tubulopathy lack a diagnosis.We performed whole-exome -genome sequencing patient cohort novel, inherited, salt-losing tubulopathy; hypomagnesemia; dilated cardiomyopathy. We also conducted subsequent vitro functional analyses identified variants RRAGD, gene that encodes small Rag guanosine...

10.1681/asn.2021030333 article EN Journal of the American Society of Nephrology 2021-10-04
Coming Soon ...